1.Effect of Shimo Tang on the recovery of intestinal function after biliary surgery
Shitang GAO ; Zhongxiao LU ; Dongquan WU
Chinese Journal of Rehabilitation Theory and Practice 2004;10(10):622-622
目的观察中药四磨汤对胆道手术后患者肠功能恢复的影响。方法133例行胆道术患者分为治疗组(90例)和对照组(43例),治疗组患者术前2h和术后每6h口服四磨汤30—40ml,对照组患者术后采用常规治疗,观察记录两组患者肛门排气时间。结果治疗组患者术后肛门排气时间较对照组显著提前(P<0.001)。结论术前、术后口服四磨汤可有效促进胆道手术患者肠功能恢复。
2.Grading method of inhomogeneity of contrast-enhanced ultrasound for rectal tumors based on gray level co-occurrence matrix.
Yuan LUO ; Hua ZHUANG ; Langkuan QIN ; Jieying ZHAO ; Hao YIN ; Dongquan LIU ; Yuting WU ; Ke LIU ; Hanchuan HU
Journal of Biomedical Engineering 2019;36(6):964-968
Transrectal contrast-enhanced ultrasound (CEUS) is an important examination for rectal tumors. The inhomogeneity of the CEUS images has important clinical significance. However, there is no objective method to evaluate this index. In this study, a method based on gray-level co-occurrence matrix (GLCM) is proposed to extract texture features of images and grade these images according the inhomogeneity. Specific processes include compressing the gray level of the image, calculating the texture statistics of gray level co-occurrence matrix, combining feature selection and principal component analysis (PCA) for dimensionality reduction, and training and validating quadratic discriminant analysis (QDA). After ten cross-validation, the overall accuracy rate of machine classification was 87.01%, and the accuracy of each level was as follows: Grade Ⅰ 52.94%, Grade Ⅱ 96.48% and Grade Ⅲ 92.35% respectively. The proposed method has high accuracy in judging grade Ⅱ and Ⅲ images, which can help to identify the grade of inhomogeneity of contrast-enhanced ultrasound images of rectal tumors, and may be used to assist clinical doctors in judging the grade of inhomogeneity of contrast-enhanced ultrasound of rectal tumors.
Discriminant Analysis
;
Humans
;
Rectal Neoplasms
;
Ultrasonography
3.Targeting macrophagic SHP2 for ameliorating osteoarthritis via TLR signaling.
Ziying SUN ; Qianqian LIU ; Zhongyang LV ; Jiawei LI ; Xingquan XU ; Heng SUN ; Maochun WANG ; Kuoyang SUN ; Tianshu SHI ; Zizheng LIU ; Guihua TAN ; Wenqiang YAN ; Rui WU ; Yannick Xiaofan YANG ; Shiro IKEGAWA ; Qing JIANG ; Yang SUN ; Dongquan SHI
Acta Pharmaceutica Sinica B 2022;12(7):3073-3084
Osteoarthritis (OA), in which M1 macrophage polarization in the synovium exacerbates disease progression, is a major cause of cartilage degeneration and functional disabilities. Therapeutic strategies of OA designed to interfere with the polarization of macrophages have rarely been reported. Here, we report that SHP099, as an allosteric inhibitor of src-homology 2-containing protein tyrosine phosphatase 2 (SHP2), attenuated osteoarthritis progression by inhibiting M1 macrophage polarization. We demonstrated that M1 macrophage polarization was accompanied by the overexpression of SHP2 in the synovial tissues of OA patients and OA model mice. Compared to wild-type (WT) mice, myeloid lineage conditional Shp2 knockout (cKO) mice showed decreased M1 macrophage polarization and attenuated severity of synovitis, an elevated expression of cartilage phenotype protein collagen II (COL2), and a decreased expression of cartilage degradation markers collagen X (COL10) and matrix metalloproteinase 3 (MMP3) in OA cartilage. Further mechanistic analysis showed thatSHP099 inhibited lipopolysaccharide (LPS)-induced Toll-like receptor (TLR) signaling mediated by nuclear factor kappa B (NF-κB) and PI3K-AKT signaling. Moreover, intra-articular injection of SHP099 also significantly attenuated OA progression, including joint synovitis and cartilage damage. These results indicated that allosteric inhibition of SHP2 might be a promising therapeutic strategy for the treatment of OA.